About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Hematology/Oncology
›
top-articles
Division of Hematology/Oncology
149
(top 1%)
papers
6.4K
(top 1%)
citations
37
(top 1%)
h
-index
79
(top 1%)
g
-index
152
all documents
6.6K
doc citations
1.2K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Leukemia
2008
787
2
Graft-versus-myeloma effect: proof of principle
Blood
1996
525
3
Superiority of Tandem Autologous Transplantation Over Standard Therapy for Previously Untreated Multiple Myeloma
Blood
1997
520
4
Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients
Blood
1995
430
5
Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities
Blood
1995
361
6
Optimizing the Correlation between Results of Testing In Vitro and Therapeutic Outcome In Vivo for Fluconazole by Testing Critical Isolates in a Murine Model of Invasive Candidiasis
Antimicrobial Agents and Chemotherapy
1998
168
7
Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support
Blood
1992
164
8
High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants
Blood
1994
164
9
Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma
British Journal of Haematology
1996
148
10
Autotransplants in multiple myeloma: what have we learned?
Blood
1996
146
11
Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma.
Journal of Clinical Oncology
1998
145
12
Graft-versus-myeloma effect: proof of principle
Blood
1996
139
13
Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma
Blood
1997
123
14
Collection, Tumor Contamination, and Engraftment Kinetics of Highly Purified Hematopoietic Progenitor Cells to Support High Dose Therapy in Multiple Myeloma
Blood
1998
108
15
Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data
Cancer
2001
105
16
Strategies for Avoiding Burnout in Hospice and Palliative Medicine: Peer Advice for Physicians on Achieving Longevity and Fulfillment
Journal of Palliative Medicine
2009
104
17
Racial differences in the outcome of patients with colorectal carcinoma
Cancer
2003
99
18
Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients
Blood
1995
96
19
Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma
American Journal of Hematology
2003
85
20
Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma
Bone Marrow Transplantation
1997
83
21
Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities
Blood
1995
83
22
Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer
Annals of Thoracic Surgery
2000
77
23
Nutritional Evaluation and Supplementation of Elderly Subjects Participating in a "Meals on Wheels" Program
Journal of Parenteral and Enteral Nutrition
1985
74
24
Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors
Journal of Oncology Pharmacy Practice
2017
72
25
Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells [see comments]
Blood
1996
71
26
Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) have a Markedly Increased Rate of Second Malignancy, which is the Most Common Cause of Death
Leukemia and Lymphoma
2004
66
27
Thrombin receptor expression is upregulated in prostate cancer
Prostate
2006
66
28
Stage-Specific Characterization of the Vascular Endothelial Growth Factor Axis in Prostate Cancer: Expression of Lymphangiogenic Markers Is Associated with Advanced-Stage Disease
Clinical Cancer Research
2005
64
29
Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support
Blood
1992
59
30
Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium
Leukemia Research
2004
58
31
Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy
Bone Marrow Transplantation
1995
58
32
Bone marrow transplantation in multiple myeloma
Bone Marrow Transplantation
1991
54
33
Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease
Clinical Cancer Research
2005
54
34
Autotransplants in multiple myeloma: what have we learned?
Blood
1996
53
35
Role of EZH2 histone methyltrasferase in melanoma progression and metastasis
Cancer Biology and Therapy
2016
51
36
CYTOGENETICS AND MOLECULAR GENETICS IN MULTIPLE MYELOMA
Hematology/Oncology Clinics of North America
1997
50
37
BIOLOGY AND THERAPY OF IMMUNOGLOBULIN DEPOSITION DISEASES
Hematology/Oncology Clinics of North America
1997
48
38
Severe Hemorrhagic Complication Due to Acquired Factor V Inhibitor After Single Exposure to Bovine Thrombin Product
Journal of Cardiac Surgery
2010
42
39
Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity
Anticancer Research
1996
37
40
Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack
Cancer Biology and Therapy
2017
35
41
Case report of sideroblastic anemia caused by ingestion of coins
American Journal of Hematology
2001
33
42
Autotransplants in multiple myeloma: what have we learned?
Blood
1996
31
43
Bilateral iris tumors in an immunosuppressed child
Survey of Ophthalmology
1991
30
44
Evaluation of Vitamin D Deficiency in Breast Cancer Patients on Bisphosphonates
Oncologist
2008
30
45
Role of colony-stimulating factor in myelopoiesis in murine long-term bone marrow cultures
Blood
1987
29
46
Targeting nano drug delivery to cancer cells using tunable, multi‐layer, silver‐decorated gold nanorods
Journal of Applied Toxicology
2017
29
47
Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support
Blood
1992
29
48
Calreticulin associates with stress proteins: Implications for chaperone function during heat stress
Blood
1998
28
49
Autologous Bone Marrow Transplantation for Multiple Myeloma
Hematology/Oncology Clinics of North America
1992
27
50
High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma
Blood
1990
27
site/software ©
exaly
; All materials licenced under
CC by-SA
.